{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:00:32Z","timestamp":1790834432902,"version":"4.1.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cognitive impairment is highly prevalent across psychiatric disorders, but it remains unclear how psychiatric morbidity and diagnostic category contribute to its presence and profile and whether inflammation and salivary synaptic proteins are associated with cognitive impairment across diagnoses. This transdiagnostic study integrated clinical, cognitive, inflammatory, and salivary biomarker data to examine these questions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Cross-sectional assessment of 131 participants (controls,\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f63; major depressive disorder,\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f20; schizophrenia,\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f20; substance use disorder,\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f28). Systemic inflammation was indexed by neutrophil-to-lymphocyte ratio (NLR). Salivary synaptophysin (SYP), synaptotagmin-1 (SYT1), and synapsin-II (SYN2) were quantified as exploratory biomarkers. Logistic, multinomial, and linear regression models were used to identify variables independently associated with cognitive impairment, subjective distress, and inflammation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The presence of any psychiatric disorder was the strongest independent correlate of cognitive impairment (OR\u202f=\u202f5.23, 95% CI 2.05\u201313.35). Exploratory diagnosis-specific analyses suggested heterogeneity in cognitive, inflammatory, and psychosocial profiles. NLR was associated with psychiatric morbidity but was not independently associated with cognitive impairment. SYP showed an exploratory association with cognitive impairment (OR\u202f=\u202f0.993 per ng\/mL increase; corresponding OR\u202f=\u202f0.681 across the observed interquartile range), although this finding was attenuated in sensitivity analyses and should be interpreted cautiously. Subjective distress was not independently associated with diagnosis or biomarkers but was strongly associated with health-related quality of life (HRQoL) (SF-12 physical and mental components; Nagelkerke\n                      <jats:italic>R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u202f=\u202f0.734), indicating a distinct psychosocial dimension; however, this finding should be interpreted cautiously because of conceptual overlap between self-reported constructs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations<\/jats:title>\n                    <jats:p>Cross-sectional design precludes causal inference. Sample size limits statistical power for diagnostic subgroup comparisons. The neuropsychological assessor was not blinded to participants\u2019 diagnostic status. Universal psychopharmacological treatment precludes disentangling illness from medication effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Psychiatric morbidity was associated with the presence of cognitive impairment in this baseline cross-sectional analysis, whereas the diagnostic category may contribute to heterogeneity in the impairment profile. Systemic inflammation was associated with psychiatric morbidity but was not independently associated with cognitive impairment. Subjective distress was strongly associated with HRQoL and appeared largely independent of the biological markers examined. These findings support an integrative multilevel framework in which cognitive impairment and HRQoL represent complementary transdiagnostic dimensions. Routine cognitive screening across psychiatric settings may be warranted. The observed SYP and HRQoL associations should be considered hypothesis-generating and require longitudinal validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyg.2026.1913919","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:42:13Z","timestamp":1790833333000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychiatric morbidity is associated with cognitive impairment, whereas diagnostic category may shape its profile: a transdiagnostic study of inflammation, salivary biomarkers, and health-related quality of life"],"prefix":"10.3389","volume":"17","author":[{"given":"Andrea","family":"P\u00e9rez-Rivas","sequence":"first","affiliation":[{"name":"Translational Neuroscience Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO","place":["Vigo, Spain"]},{"name":"Primary Care Addiction Research Network (RIAPAD)","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Iglesias Mart\u00ednez-Almeida","sequence":"additional","affiliation":[{"name":"Translational Neuroscience Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO","place":["Vigo, Spain"]},{"name":"Grup de recerca en Nutrici\u00f3 Funcional, Oxidaci\u00f3 i Malalties Cardiovasculars (NFOC-Salut) - Universitat Rovira i Virgili (URV)","place":["Reus, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Aguayo","family":"Arjona","sequence":"additional","affiliation":[{"name":"Statistics and Methodology Unit, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO","place":["Vigo, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"S\u00e1nchez Luaces","sequence":"additional","affiliation":[{"name":"Translational Neuroscience Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO","place":["Vigo, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Rodr\u00edguez Bern\u00e1rdez","sequence":"additional","affiliation":[{"name":"AFAGA Alzheimer Centre","place":["Vigo, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Vicente Alba","sequence":"additional","affiliation":[{"name":"Psychiatry Service","place":["Vigo, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Elena","family":"de las Heras Linero","sequence":"additional","affiliation":[{"name":"Translational Neuroscience Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO","place":["Vigo, Spain"]},{"name":"Psychiatry Service","place":["Vigo, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Pi\u00f1\u00f3n-Blanco","sequence":"additional","affiliation":[{"name":"Translational Neuroscience Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO","place":["Vigo, Spain"]},{"name":"Primary Care Addiction Research Network (RIAPAD)","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Rivera-Baltan\u00e1s","sequence":"additional","affiliation":[{"name":"Translational Neuroscience Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO","place":["Vigo, Spain"]},{"name":"Primary Care Addiction Research Network (RIAPAD)","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Navarro-Bardon","sequence":"additional","affiliation":[{"name":"Translational Neuroscience Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO","place":["Vigo, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Abalde-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Translational Neuroscience Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO","place":["Vigo, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"del Carmen Vallejo-Curto","sequence":"additional","affiliation":[{"name":"Translational Neuroscience Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO","place":["Vigo, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Otero-Lamas","sequence":"additional","affiliation":[{"name":"Translational Neuroscience Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO","place":["Vigo, Spain"]},{"name":"Primary Care Addiction Research Network (RIAPAD)","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Campos-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Translational Neuroscience Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO","place":["Vigo, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"L\u00f3pez-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Translational Neuroscience Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO","place":["Vigo, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Olivares","sequence":"additional","affiliation":[{"name":"Translational Neuroscience Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO","place":["Vigo, Spain"]},{"name":"Primary Care Addiction Research Network (RIAPAD)","place":["Barcelona, Spain"]},{"name":"Biomedical Research Center Network for Mental Health (CIBERSAM)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Spuch","sequence":"additional","affiliation":[{"name":"Translational Neuroscience Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO","place":["Vigo, Spain"]},{"name":"Primary Care Addiction Research Network (RIAPAD)","place":["Barcelona, Spain"]},{"name":"Biomedical Research Center Network for Mental Health (CIBERSAM)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"102007","DOI":"10.1016\/j.cpr.2021.102007","article-title":"The C factor: cognitive dysfunction as a transdiagnostic dimension in psychopathology","volume":"86","author":"Abramovitch","year":"2021","journal-title":"Clin. Psychol. Rev."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12955-017-0781-y","article-title":"Comparison of health-related quality of life among men with different co-existing severe mental disorders in treatment for substance use","volume":"15","author":"Adan","year":"2017","journal-title":"Health Qual. Life Outcomes"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/wps.20894","article-title":"Risk and protective factors for mental disorders beyond genetics: an evidence-based atlas","volume":"20","author":"Arango","year":"2021","journal-title":"World Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/dar.12922","article-title":"Prevalence of cognitive impairment in patients with substance use disorder","volume":"38","author":"Bruijnen","year":"2019","journal-title":"Drug Alcohol Rev."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.4149\/BLL_2024_73","article-title":"Evaluation of systemic immune inflammation index and neutrophil-to-lymphocyte ratio in schizophrenia, bipolar disorder and depression","volume":"125","author":"Canli","year":"2024","journal-title":"Bratisl. Med. J."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"6640130","DOI":"10.1155\/2024\/6640130","article-title":"Neutrophil-lymphocytes ratio as potential early marker for Alzheimer's disease","volume":"2024","author":"Cervellati","year":"2024","journal-title":"Mediat. Inflamm."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22052761","article-title":"Machine learning and novel biomarkers for the diagnosis of alzheimer's disease","volume":"22","author":"Chang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1552451","DOI":"10.3389\/fpsyt.2025.1552451","article-title":"Neutrophil-to-lymphocyte ratio; platelet-to-lymphocyte ratio; systemic immune-inflammatory index: inflammatory indicators of cognitive impairment in schizophrenia patients","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Psych."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"453","DOI":"10.12740\/PP\/OnlineFirst\/105415","article-title":"Cognitive dysfunctions in depression - significance, description and treatment prospects","volume":"54","author":"Czerwi\u0144ska","year":"2020","journal-title":"Psychiatr. Pol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"S159","DOI":"10.1093\/schbul\/sbaa030.375","article-title":"Transdiagnostic neurocognitive deficits in psychiatry: a review of meta-analyses","volume":"46","author":"East-Richard","year":"2020","journal-title":"Schizophr. Bull."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.36131\/cnfioritieditore20240203","article-title":"A moderated mediation model of age-related decline in selective executive functions and quality of life in men with substance use disorder","volume":"21","author":"Fatima","year":"2024","journal-title":"Clin. Neuropsychiatry"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12888-020-2459-y","article-title":"Defining cognitive and functional profiles in schizophrenia and affective disorders","volume":"20","author":"Huang","year":"2020","journal-title":"BMC Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1037\/abn0000258","article-title":"The hierarchical taxonomy of psychopathology (HiTOP): a dimensional alternative to traditional nosologies","volume":"126","author":"Kotov","year":"2017","journal-title":"J. Abnorm. Psychol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1002\/alz.14049","article-title":"The risk of Alzheimer's disease and cognitive impairment characteristics in eight mental disorders: a UK biobank observational study and mendelian randomization analysis","volume":"20","author":"Liu","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/schbul\/sbz111","article-title":"Transdiagnostic dysfunctions in brain modules across patients with schizophrenia, bipolar disorder, and major depressive disorder: a connectome-based study","volume":"46","author":"Ma","year":"2020","journal-title":"Schizophr. Bull."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"705998","DOI":"10.3389\/fpsyt.2021.705998","article-title":"Common and distinct alterations of cognitive function and brain structure in schizophrenia and major depressive disorder: a pilot study","volume":"12","author":"Ma","year":"2021","journal-title":"Front. Psych."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00406-023-01731-6","article-title":"Improving outcome of treatment-resistant schizophrenia: effects of cognitive remediation therapy","volume":"274","author":"Martini","year":"2024","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.33588\/rn.7507.2022113","article-title":"Cuestionario de reserva cognitiva: an\u00e1lisis psicom\u00e9trico desde la teor\u00eda de respuesta al \u00edtem","volume":"75","author":"Martino","year":"2022","journal-title":"Rev. Neurol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/23279095.2017.1392962","article-title":"Cognitive impairment in schizophrenia and depression: a comparison of stability and course","volume":"26","author":"Neu","year":"2019","journal-title":"Appl. Neuropsychol. Adult"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"488","DOI":"10.33588\/rn.6311.2016241","article-title":"Test de evaluaci\u00f3n cognitiva de Montreal: normalizaci\u00f3n y estandarizaci\u00f3n de la prueba en poblaci\u00f3n espa\u00f1ola","volume":"63","author":"Ojeda","year":"2016","journal-title":"Rev. Neurol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s41999-025-01278-w","article-title":"Sex differences in health-related quality of life among individuals at high risk of dementia","volume":"16","author":"Oliveira","year":"2025","journal-title":"Eur. Geriatr. Med."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"100193","DOI":"10.1016\/j.tjpad.2025.100193","article-title":"Value of blood neural cell-derived small extracellular vesicles in the diagnosis and prediction of Alzheimer's disease: a systematic review","volume":"12","author":"Pan","year":"2025","journal-title":"J. Prev Alzheimers Dis."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jad.2019.05.063","article-title":"Effects of depression and cognitive impairment on quality of life in older adults with schizophrenia spectrum disorder: results from a multicenter study","volume":"256","author":"Pascal de Raykeer","year":"2019","journal-title":"J. Affect. Disord."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/arclin\/acp043","article-title":"Spanish multicenter normative studies (NEURONORMA project): norms for the Stroop color-word interference test and the tower of London-Drexel","volume":"24","author":"Pe\u00f1a-Casanova","year":"2009","journal-title":"Arch. Clin. Neuropsychol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/arclin\/acp038","article-title":"Spanish multicenter normative studies (NEURONORMA project): norms for verbal span, visuospatial span, letter and number sequencing, trail making test, and symbol digit modalities test","volume":"24","author":"Pe\u00f1a-Casanova","year":"2009","journal-title":"Arch. Clin. Neuropsychol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3233\/JAD-201349","article-title":"The utility of assessing health-related quality of life to predict cognitive decline and dementia","volume":"80","author":"Phyo","year":"2021","journal-title":"J. Alzheimer's Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1017\/S1138741600006004","article-title":"Psychometric properties of a European Spanish version of the perceived stress scale (PSS)","volume":"9","author":"Remor","year":"2006","journal-title":"Span. J. Psychol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"105835","DOI":"10.1016\/j.actpsy.2025.105835","article-title":"Characterization of cognitive impairment and contributing factors in patients with substance use disorders: influence of primary alcohol or cocaine use","volume":"261","author":"Reviriego","year":"2025","journal-title":"Acta Psychol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000535665","article-title":"Neuropsychological assessments of cognitive impairment in major depressive disorder: a systematic review and Meta-analysis with Meta-regression","volume":"93","author":"Rhee","year":"2024","journal-title":"Psychother. Psychosom."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3390\/brainsci16060550","article-title":"Biomarkers for predicting clinical deterioration in schizophrenia-Spectrum disorders: a systematic review","volume":"16","author":"Ricci","year":"2026","journal-title":"Brain Sci."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.nrl.2012.02.009","article-title":"Estudios normativos espa\u00f1oles en poblaci\u00f3n adulta joven (proyecto NEURONORMA j\u00f3venes): normas para las pruebas Stroop Color-Word Interference Test y Tower of London-Drexel University","volume":"28","author":"Rognoni","year":"2013","journal-title":"Neurologia"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1017\/S003329172400206X","article-title":"Longitudinal course of inflammatory-cognitive subgroups across first treatment severe mental illness and healthy controls","volume":"54","author":"S\u00e6ther","year":"2024","journal-title":"Psychol. Med."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.33588\/rn.7202.2020412","article-title":"Hopkins verbal learning test-revised: normalization and standardization for Spanish population","volume":"72","author":"S\u00e1ez-Atxukarro","year":"2021","journal-title":"Rev. Neurol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.medcli.2011.10.024","article-title":"Normas de referencia para el Cuestionario de Salud SF-12 versi\u00f3n 2 basadas en poblaci\u00f3n general de Catalu\u00f1a","volume":"139","author":"Schmidt","year":"2012","journal-title":"Med. Clin. (Barc.)"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.1017\/S0033291723001770","article-title":"Prevalence of cognitive impairments and strengths in the early course of psychosis and depression","volume":"53","author":"Stainton","year":"2023","journal-title":"Psychol. Med."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.12809\/eaap2502","article-title":"Cognitive impairment and elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in schizophrenia","volume":"35","author":"Syahna","year":"2025","journal-title":"East Asian Arch. Psychiatr."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.nrl.2011.12.020","article-title":"Estudios normativos espa\u00f1oles en poblaci\u00f3n adulta joven (Proyecto NEURONORMA j\u00f3venes): normas para las pruebas span verbal, span visuoespacial, Letter-Number Sequencing, Trail Making Test y Symbol Digit Modalities Test","volume":"27","author":"Tamayo","year":"2012","journal-title":"Neurologia"},{"key":"ref38","first-page":"163","article-title":"Propiedades psicom\u00e9tricas de la Escala Hospitalaria de Ansiedad y Depresi\u00f3n (HAD) en poblaci\u00f3n espa\u00f1ola","volume":"13","author":"Terol","year":"2007","journal-title":"Ansiedad Estr\u00e9s"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"152498","DOI":"10.1016\/j.comppsych.2024.152498","article-title":"Identifying internalizing transdiagnostic profiles through motivational and cognitive control systems: relations with symptoms, functionality, and quality of life","volume":"133","author":"Verdejo-Garcia","year":"2024","journal-title":"Compr. Psychiatry"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3233\/JAD-160611","article-title":"What is the relationship between health, mood, and mild cognitive impairment?","volume":"55","author":"Yates","year":"2017","journal-title":"J. Alzheimer's Dis"}],"container-title":["Frontiers in Psychology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2026.1913919\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:42:14Z","timestamp":1790833334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2026.1913919\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":40,"alternative-id":["10.3389\/fpsyg.2026.1913919"],"URL":"https:\/\/doi.org\/10.3389\/fpsyg.2026.1913919","relation":{},"ISSN":["1664-1078"],"issn-type":[{"value":"1664-1078","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"1913919"}}